Chicago Atlantic BDC, Inc. (NASDAQ: LIEN) operates as a specialty finance company regulated as a business development company, with a focus on direct lending to cannabis companies. Analyst coverage remains limited, which is common for smaller, niche BDCs like this one. Across the few tracked estimates, the price target sits at $11.00. Oppenheimer analyst Mitchel Penn initiated coverage with a Hold rating and $11.00 target in April 2025 and has since reiterated that view. Aggregated data from MarketWatch and other sources show a narrow high-low range of roughly $11.00 to $11.00, producing an average of exactly $11.00. With every published target at the same level, there is no meaningful dispersion between bullish and cautious perspectives.
The reasoning behind the $11.00 target is not detailed publicly, but Hold-rated BDC targets often reflect the view that the dividend yield and modest net-asset-value growth are already priced in. Thin coverage means this figure serves more as a single reference point than a robust consensus.
At a recent verified price near $8.99, the stock would need to rise about 22% to reach $11.00. The share price has drifted lower over the trailing year and now sits near the bottom of its 52-week range of roughly $8.92 to $11.27. The $11.00 target therefore aligns with levels the stock has already traded at during the past year. The announced all-stock merger with Chicago Atlantic Real Estate Finance, expected to leave LIEN as the surviving BDC, stands as the central development ahead. If the combination closes smoothly and expands the lending book and earnings power, it could support a move toward the target. At the same time, a BDC trading below its target while distributing most income as dividends can take time to close any gap, since total return depends heavily on distributions rather than price appreciation alone. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The stock's 52-week range of roughly $8.92 to $11.27 provides the clearest technical context. The $11.00 target sits just below the upper end of that range, aligning with a prior price zone the stock has already reached. The $8.92-to-$9.00 area has acted as a support level in recent trading, while $11.00-to-$11.27 marks a resistance level. A sustained move toward the target would likely require the stock to hold above its recent low and build momentum through the low-to-mid single digits before testing that upper band. From what I see, the technical setup remains consistent with the analyst anchor point.
Analyst price targets generally reflect a research horizon of roughly 12 months, though the specific horizon behind the $11.00 target is not publicly disclosed. Investors should watch the closing of the REFI merger, subsequent quarterly results and EPS, dividend declarations, and any changes in non-accrual or impaired loans, which signal credit quality. Regulatory developments affecting cannabis lending and broader interest-rate policy, which influences BDC borrowing costs and net interest margins, also matter. I’m watching this closely as the merger timeline unfolds.
In my own analysis, I occasionally reference Tickeron’s AI Daily Buy/Sell Signals to monitor how LIEN and similar names behave under changing market conditions. The tool applies artificial intelligence to scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on technical behavior and broader trends. It serves as a useful complement when reviewing the factors discussed above.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
LIEN saw its Momentum Indicator move below the 0 level on November 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 114 similar instances where the indicator turned negative. In 81 of the 114 cases, the stock moved further down in the following days. The odds of a decline are at 71%.
The Moving Average Convergence Divergence Histogram (MACD) for LIEN turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 31 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIEN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
The Aroon Indicator for LIEN entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for LIEN's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIEN advanced for three days, in 111 of 201 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.
LIEN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 68 (best 1 - 100 worst), indicating slightly worse than average price growth. LIEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.684) is normal, around the industry mean (2.423). P/E Ratio (6.525) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.318). Dividend Yield (0.150) settles around the average of (0.274) among similar stocks. P/S Ratio (5.811) is also within normal values, averaging (15.906).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentManagers